Exercise or conversion by Rickey James Paul of 10989 shares of Alpine Immune subject to Rule 16b-3
About 67% of Alpine Immune's investor base is looking to short. The analysis of current outlook of investing in Alpine Immune Sciences suggests that many traders are alarmed regarding Alpine Immune's prospects. Alpine Immune's investing sentiment overview a quick insight into current market opportunities from investing in Alpine Immune Sciences. Many technical investors use Alpine Immune Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Alpine |
Filed transaction by Alpine Immune Sciences In officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Alpine Immune Fundamental Analysis
We analyze Alpine Immune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Alpine Immune is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Alpine Immune Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alpine Immune stock to make a market-neutral strategy. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics with similar companies.
Peers
Alpine Immune Related Equities
| AMLX | Amylyx Pharmaceuticals | 3.80 | ||||
| ANAB | AnaptysBio | 2.56 | ||||
| ABOS | Acumen Pharmaceuticals | 1.59 | ||||
| IGMS | IGM Biosciences | 1.49 | ||||
| TNYA | Tenaya Therapeutics | 1.00 | ||||
| GLUE | Monte Rosa | 0.92 | ||||
| MLTX | MoonLake Immunotherapeuti | 0.02 | ||||
| BCYC | Bicycle Therapeutics | 0.54 | ||||
| ACRV | Acrivon Therapeutics, | 0.56 | ||||
| ADAG | Adagene | 0.99 | ||||
| STOK | Stoke Therapeutics | 1.75 | ||||
| TERN | Terns Pharmaceuticals | 1.86 | ||||
| ANEB | Anebulo Pharmaceuticals | 3.33 | ||||
| DAWN | Day One | 4.03 | ||||
| MLYS | Mineralys Therapeutics, | 8.23 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets |